NANOCOR THERAPEUTICS, INC.

Company Information

Company Name
NANOCOR THERAPEUTICS, INC.
Address
870 MARTIN LUTHER KING JR BLVD
CHAPEL HILL, NC, 27514-2600
Phone
n/a
URL
n/a
DUNS
6064300
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$640,383.00
1
SBIR Phase II
$2,623,563.00
1

Award List

  1. Gene Based Therapy for Congestive Heart Failure

    Amount: $640,383.00

    DESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and increment ...

    SBIR Phase I 2012 Department of Health and Human Services
  2. Gene Based Therapy for Congestive Heart Failure P2 SBIR

    Amount: $2,623,563.00

    DESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and increment ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government